Brind.

Nektar Therapeutics' stock doubled following the release of positive trial results.

1 report, 0 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Nektar Therapeutics Investopedia

Keep exploring

The entities involved

Nektar Therapeutics
American healthcare company
- Nektar Therapeutics' board granted stock options to new employees on October 23, 2026.Fri 22:38
Investopedia
website focused on finance and investing

Nothing else this week.

Related events

Leerink Partners assumed coverage on Nektar Therapeutics shares on October 13, 2026.Oct 13

Coverage

Newest first; wire copies grouped

Jun 24Unknown outlet